Melagiri Sridhar, Chief Financial Officer, Bafna Pharmaceuticals in a recent interaction with India Pharma Outlook, shared his views on how CFOs in the pharmaceutical industry should balance investments in advanced stability-enhancing technologies...

In an interaction with India Pharma Outlook, Ajay Bhardwaj, CEO, Anthem Biosciences Private Limited discusses about the role of organic synthesis in accelerating drug discovery, highlighted the significance of diligence at an early stage, AI-driven..

In an interaction with India Pharma Outlook, Vivek Soares, Country Lead, India and South Asia, Organon, discusses the progress and gaps in women’s healthcare, emphasizing the need for gender-specific research, improved access, policy reforms...

In an interaction with India Pharma Outlook, Sanjay Vyas, President, Global Head of Safety Services &Clinical Logistics, and Managing Director, India at Parexel, discusses ways in which Indian pharma firmsstrengthen clinical trial supply chains

Rajiv Gupta, Country Business Leader (Healthcare Business) at 3M India Limited in an exclusive interaction with India Pharma Outlook, discusses the growth of India's medical device market, noting that 70 percent of devices are still imported...

In an exclusive interview with India Pharma Outlook, Amit Sehgal, VP & GM - Lab Solutions Segment, AMEA, Avantor, emphasizes how the Indian scientific sector is facing a quality problem owing to skyrocketing demand, which has put tremendous pressu...